Edmonton – TheNewswire - October 25th, 2022 - Innovotech Inc. (TSXV:IOT) has granted 150,000 incentive stock options under its stock option plan exercisable at $0.16 per share to 6 directors of the Company in the amount of 25,000 per director.  The options are for 5 years and expire on October 11th, 2027.

The Company also advises that Dr. Gerard Tertzakian has retired from the Board after 20 years as a Director.  Gerry was a Founder, former President and CEO, of Innovotech.  All of us at Innovotech thank him for his valued service and long commitment to the Company.

About Innovotech:

Innovotech is a Canadian biotechnology company owning proprietary intellectual property, conducting contract research, and owning and providing proprietary devices for testing in multiple applications in microbiology.  Innovotech can be found online at www.innovotech.ca.

On behalf of the Board of Directors,

Alan Savage,

Director and CFO

Innovotech Inc.

604 220-4935

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.